BeyondSpring Sells $35.4 Million Stake in SEED Therapeutics to Strategic Investors
I'm PortAI, I can summarize articles.
BeyondSpring Inc. has agreed to sell 8,333,637 Series A-1 Preferred Shares of SEED Therapeutics for $35.4 million. The shares are priced at $4.25 each, with Winning View Investment Limited, FULL TECH CORPORATE DEVELOPMENT LIMITED, and Mapfil Investment Limited as buyers. The transactions are expected to close in the first half of 2026, with potential delays. This information was published by BeyondSpring via the SEC's EDGAR system.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments